Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Lack Of Early Clinical Response To Treatment With Baricitinib Predicts Low Probability Of Achieving Long Term DAS28-ESR Low Disease Activity Or Remission In Patients With Rheumatoid Arthritis. Keystone, E., Genovese, M. C., Taylor, P., Zhu, B., Beattie, S. D., de Bono, S., Rooney, T., Schlichting, D. E., Macias, W. WILEY-BLACKWELL. 2013: S607
View details for Web of Science ID 000325359203414